does tirzepatide cancel out birth control and Tirzepatide: Safety Interactions Zepbound and Birth Control: Drug

The pivotal Phase 2 trial a 48-week study published in The New England Journal of Medicine in 2023 produced these results in adults with obesity (and no diabetes), at the highest dose of 12 mg weekly: Average weight loss of around 24% from baseline A clear dose-response, with even the 4 mg dose producing roughly 17% weight loss Continued weight loss right up to the 48-week endpoint, with no plateau in sight For context, similar Phase 2 data for Wegovy showed around 15% weight loss at 68 weeks

Related: 2026 Part D Updates & Carrier Highlights The TrumpRx Option Even if your clients don't qualify for Medicare coverage, they'll have a new lower-cost option starting January 2026

These microorganisms form a large and complex ecosystem in the human gut and play important regulatory roles in human health and disease

Set a clear, observable goal before starting so you can judge whether it's actually helping